SG-1

N/A

Report date: 2025/09/11 17:39:33
NMEFirst In Class

Base Information

Drug NameSG-1
Drug Alias NameSG-1SG-1001SG1001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDihydroorotate dehydrogenase inhibitors
TargetsDihydroorotate dehydrogenase
Therapy Area/IndicationsInvasive Fungal InfectionsAspergillosisMycoses +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesShenzhen Xianggen Biology Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesLivzon Pharmaceutical Group IncShenzhen Xianggen Biology Co LtdLivzon(Group) Pharmaceutical Factory
Inactive CompaniesN/A
Active IndicationsInvasive Fungal InfectionsAspergillosisMycoses +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A